Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II.

Rius, Cristina

Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II. [electronic resource] - Arteriosclerosis, thrombosis, and vascular biology Jan 2013 - 96-104 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1524-4636

10.1161/ATVBAHA.112.254870 doi


Angiotensin II--metabolism
Angiotensin II Type 1 Receptor Blockers--pharmacology
Animals
Apolipoproteins E--genetics
Arteries--drug effects
Arterioles--drug effects
Atherosclerosis--genetics
CX3C Chemokine Receptor 1
Cell Adhesion
Cells, Cultured
Chemokine CX3CL1--genetics
Disease Models, Animal
Endothelial Cells--drug effects
Extracellular Signal-Regulated MAP Kinases--metabolism
Female
Human Umbilical Vein Endothelial Cells--metabolism
Humans
Interferon-gamma--metabolism
Leukocyte Rolling
Leukocytes--metabolism
Losartan--pharmacology
Male
Membrane Glycoproteins--genetics
Membrane Proteins--genetics
Mice
Mice, Inbred C57BL
Mice, Knockout
NADPH Oxidase 2
NADPH Oxidase 4
NADPH Oxidase 5
NADPH Oxidases--genetics
NF-kappa B--metabolism
RNA Interference
Receptors, Chemokine--genetics
Signal Transduction
Time Factors
Transfection
Tumor Necrosis Factor-alpha--genetics
Veins--drug effects
Venules--drug effects
p38 Mitogen-Activated Protein Kinases--metabolism